35 related articles for article (PubMed ID: 7720180)
21. Urinary platinum in hospital personnel occupationally exposed to platinum-containing antineoplastic drugs.
Ensslin AS; Pethran A; Schierl R; Fruhmann G
Int Arch Occup Environ Health; 1994; 65(5):339-42. PubMed ID: 8175190
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function.
Harland SJ; Newell DR; Siddik ZH; Chadwick R; Calvert AH; Harrap KR
Cancer Res; 1984 Apr; 44(4):1693-7. PubMed ID: 6367971
[TBL] [Abstract][Full Text] [Related]
23. Peripheral sensory neuropathy and cisplatin chemotherapy.
Roelofs RI; Hrushesky W; Rogin J; Rosenberg L
Neurology; 1984 Jul; 34(7):934-8. PubMed ID: 6330613
[TBL] [Abstract][Full Text] [Related]
24. Noninvasive monitoring of drug biodistribution and metabolism: studies with intraarterial Pt-195m-cisplatin in humans.
Shani J; Bertram J; Russell C; Dahalan R; Chen DC; Parti R; Ahmadi J; Kempf RA; Kawada TK; Muggia FM
Cancer Res; 1989 Apr; 49(7):1877-81. PubMed ID: 2924326
[TBL] [Abstract][Full Text] [Related]
25. Cisplatin nephrotoxicity.
Fillastre JP; Raguenez-Viotte G
Toxicol Lett; 1989 Mar; 46(1-3):163-75. PubMed ID: 2650023
[TBL] [Abstract][Full Text] [Related]
26. Cisplatin-based combination chemotherapy for disseminated germ cell tumors: long-term follow-up.
Roth BJ; Greist A; Kubilis PS; Williams SD; Einhorn LH
J Clin Oncol; 1988 Aug; 6(8):1239-47. PubMed ID: 2457658
[TBL] [Abstract][Full Text] [Related]
27. Acute and long-term nephrotoxicity of cis-platinum in man.
Groth S; Nielsen H; Sørensen JB; Christensen AB; Pedersen AG; Rørth M
Cancer Chemother Pharmacol; 1986; 17(2):191-6. PubMed ID: 2424627
[TBL] [Abstract][Full Text] [Related]
28. Is cisplatin a human carcinogen?
Greene MH
J Natl Cancer Inst; 1992 Mar; 84(5):306-12. PubMed ID: 1738180
[TBL] [Abstract][Full Text] [Related]
29. [The long-term toxicity of polychemotherapy in successfully treated testicular carcinoma].
Schwabe HR; Herrmann R; Mathew M; Gräf KJ; Sander T; Cordes M; Nagel R; Weissbach L; Huhn D
Dtsch Med Wochenschr; 1992 Jan; 117(4):121-6. PubMed ID: 1733695
[TBL] [Abstract][Full Text] [Related]
30. Platinum in the human diet, blood, hair and excreta.
Vaughan GT; Florence TM
Sci Total Environ; 1992 Jan; 111(1):47-58. PubMed ID: 1542781
[TBL] [Abstract][Full Text] [Related]
31. Kinetics of cis-dichlorodiammineplatinum.
Gormley PE; Bull JM; LeRoy AF; Cysyk R
Clin Pharmacol Ther; 1979 Mar; 25(3):351-7. PubMed ID: 761445
[TBL] [Abstract][Full Text] [Related]
32. Nephrotoxicity of cis-dichlorodiammineplatinum(II).
Krakoff IH
Cancer Treat Rep; 1979; 63(9-10):1523-5. PubMed ID: 498152
[No Abstract] [Full Text] [Related]
33. Toxic effects of cis-dichlorodiammineplatinum(II) in man.
Von Hoff DD; Schilsky R; Reichert CM; Reddick RL; Rozencweig M; Young RC; Muggia FM
Cancer Treat Rep; 1979; 63(9-10):1527-31. PubMed ID: 387223
[TBL] [Abstract][Full Text] [Related]
34. Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer.
Einhorn LH; Donohue J
Ann Intern Med; 1977 Sep; 87(3):293-8. PubMed ID: 71004
[TBL] [Abstract][Full Text] [Related]
35. Long-term platinum excretion in patients treated with cisplatin.
Schierl R; Rohrer B; Hohnloser J
Cancer Chemother Pharmacol; 1995; 36(1):75-8. PubMed ID: 7720180
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
